PMV Pharmaceuticals, Inc.
PMVP
4 insider filings · Latest: Mar 5, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Oct 23, 2025 | Oct 23 10:39 PM | OrbiMed Private Investments V, LP | Proposed Sale | 1,000,000 | $1.52 | $1.5M | — | View → |
| Sep 10, 2025 | Sep 10 10:50 PM | OrbiMed Private Investments V, LP | Proposed Sale | 2,283,654 | $1.60 | $3.7M | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 5, 2026 | Mar 9 8:41 PM | Michael CarulliChief Financial Officer | Grant/Award | 240,000 | $1.53 | 240,000(D) | View → |
| Mar 5, 2026 | Mar 9 8:39 PM | Robert TicktinGeneral Counsel & COO | Grant/Award | 319,270 | $1.53 | 319,270(D) | View → |
| Mar 5, 2026 | Mar 9 8:36 PM | Deepika JalotaChief Development Officer | Grant/Award | 303,310 | $1.53 | 303,310(D) | View → |
| Mar 5, 2026 | Mar 9 8:35 PM | David Henry MackDirector, President and CEO | Grant/Award | 744,960 | $1.53 | 744,960(D) | View → |